85 related articles for article (PubMed ID: 18706823)
1. Synthesis and biodistribution of 34mCl-labeled 2-chloro-2-deoxy-d-glucose: a major impurity in [18F]FDG injection.
Fukumura T; Takei M; Suzuki K
Appl Radiat Isot; 2008 Dec; 66(12):1905-9. PubMed ID: 18706823
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of 2-deoxy-2-chloro-d-glucose impurity analysis in [(18)F]FDG by three potential-time waveforms of high-performance liquid chromatography/pulsed amperometric detection.
Farn SS; Yeh YH; Lin WJ; Shen LH
Nucl Med Biol; 2009 Feb; 36(2):225-31. PubMed ID: 19217535
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and application of [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO): a [18F]FDG-based prosthetic group for the chemoselective 18F-labeling of peptides and proteins.
Wuest F; Berndt M; Bergmann R; van den Hoff J; Pietzsch J
Bioconjug Chem; 2008 Jun; 19(6):1202-10. PubMed ID: 18481886
[TBL] [Abstract][Full Text] [Related]
4. Improved quality control of [18F]FDG by HPLC with UV detection.
Nakao R; Ito T; Yamaguchi M; Suzuki K
Nucl Med Biol; 2005 Nov; 32(8):907-12. PubMed ID: 16253817
[TBL] [Abstract][Full Text] [Related]
5. Remote control production of an aqueous solution of no-carrier-added 34mCl- via the 32S(alpha,pn) nuclear reaction.
Takei M; Nagatsu K; Fukumura T; Suzuki K
Appl Radiat Isot; 2007 Sep; 65(9):981-6. PubMed ID: 17574427
[TBL] [Abstract][Full Text] [Related]
6. Radiolysis of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) and the role of ethanol and radioactive concentration.
Jacobson MS; Dankwart HR; Mahoney DW
Appl Radiat Isot; 2009 Jun; 67(6):990-5. PubMed ID: 19231219
[TBL] [Abstract][Full Text] [Related]
7. No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine.
Niederkohr RD; Quon A
Clin Nucl Med; 2007 Apr; 32(4):302-3. PubMed ID: 17413580
[No Abstract] [Full Text] [Related]
8. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.
Hamacher K; Coenen HH; Stöcklin G
J Nucl Med; 1986 Feb; 27(2):235-8. PubMed ID: 3712040
[TBL] [Abstract][Full Text] [Related]
9. Production of 34m Cl and 38 Cl via the (d,α) reaction on 36 Ar and nat Ar gas at 8.4 MeV.
Engle JW; Barnhart TE; DeJesus OT; Nickles RJ
Appl Radiat Isot; 2011 Jan; 69(1):75-9. PubMed ID: 20884215
[TBL] [Abstract][Full Text] [Related]
10. No carrier added synthesis of O-(2'-[18F]fluoroethyl)-L-tyrosine via a novel type of chiral enantiomerically pure precursor, NiII complex of a (S)-tyrosine Schiff base.
Krasikova RN; Kuznetsova OF; Fedorova OS; Maleev VI; Saveleva TF; Belokon YN
Bioorg Med Chem; 2008 May; 16(9):4994-5003. PubMed ID: 18378460
[TBL] [Abstract][Full Text] [Related]
11. Rapid synthesis of [18F]FDG without an evaporation step using an ionic liquid.
Kim HW; Jeong JM; Lee YS; Chi DY; Chung KH; Lee DS; Chung JK; Lee MC
Appl Radiat Isot; 2004 Dec; 61(6):1241-6. PubMed ID: 15388116
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous analysis of FDG, ClDG and Kryptofix 2.2.2 in [18F]FDG preparation by high-performance liquid chromatography with UV detection.
Nakao R; Ito T; Yamaguchi M; Suzuki K
Nucl Med Biol; 2008 Feb; 35(2):239-44. PubMed ID: 18312835
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and catabolism of 18F-labeled N-epsilon-fructoselysine as a model of Amadori products.
Hultsch C; Hellwig M; Pawelke B; Bergmann R; Rode K; Pietzsch J; Krause R; Henle T
Nucl Med Biol; 2006 Oct; 33(7):865-73. PubMed ID: 17045166
[TBL] [Abstract][Full Text] [Related]
14. Preparation and preliminary biological evaluation of a novel 109Pd labeled porphyrin derivative for possible use in targeted tumor therapy.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):16-23. PubMed ID: 17372569
[TBL] [Abstract][Full Text] [Related]
15. 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Subramanian S; Sarma HD; Venkatesh M
Nucl Med Biol; 2006 May; 33(4):585-91. PubMed ID: 16720253
[TBL] [Abstract][Full Text] [Related]
16. 3,4,6-Tri-O-acetyl-2-deoxy-2-[18F]fluoroglucopyranosyl phenylthiosulfonate: a thiol-reactive agent for the chemoselective 18F-glycosylation of peptides.
Prante O; Einsiedel J; Haubner R; Gmeiner P; Wester HJ; Kuwert T; Maschauer S
Bioconjug Chem; 2007; 18(1):254-62. PubMed ID: 17226980
[TBL] [Abstract][Full Text] [Related]
17. A method to quantify at late imaging a release rate of 18F-FDG in tissues.
Laffon E; Allard M; Marthan R; Ducassou D
C R Biol; 2005 Aug; 328(8):767-72. PubMed ID: 16125654
[TBL] [Abstract][Full Text] [Related]
18. MIRD dose estimate report no. 19: radiation absorbed dose estimates from (18)F-FDG.
Hays MT; Watson EE; Thomas SR; Stabin M
J Nucl Med; 2002 Feb; 43(2):210-4. PubMed ID: 11850487
[No Abstract] [Full Text] [Related]
19. Radiolysis of 2-[18F]fluoro-2-deoxy-D-glucose (FDG) and the role of reductant stabilisers.
Fawdry RM
Appl Radiat Isot; 2007 Nov; 65(11):1193-201. PubMed ID: 17669662
[TBL] [Abstract][Full Text] [Related]
20. Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET.
Dunn JT; Anthony K; Amiel SA; Marsden PK
J Cereb Blood Flow Metab; 2009 May; 29(5):1059-67. PubMed ID: 19293824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
